Its day three of Get Smart About Antibiotics Week 2012, and today on the CDCs Safe Healthcare Blog, Infectious Diseases Society of America (IDSA) president David A. Relman, MD, FIDSA, shares the story of a healthy, active, sixth grader whose life was taken days before his 13th birthday from an antibiotic-resistant infection caused by methicillin-resistant Staphylococcus aureus (MRSA). This is just one of many tragedies caused by the alarming rise in drug-resistant infections and the lack of new antibiotics in the development pipeline.
Learn more about IDSAs ongoing efforts to find solutions to this crisis, which include antibiotic stewardship programs and research and development of new antibiotics in Relmans Safe Healthcare Blog posting at http://blogs.cdc.gov/safehealthcare/.
To learn more about Get Smart About Antibiotics Week, visit www.cdc.gov/getsmart.
From the Derby to the Decontam Room: Leadership Lessons for Sterile Processing
April 27th 2025Elizabeth (Betty) Casey, MSN, RN, CNOR, CRCST, CHL, is the SVP of Operations and Chief Nursing Officer at Surgical Solutions in Overland, Kansas. This SPD leader reframes preparation, unpredictability, and teamwork by comparing surgical services to the Kentucky Derby to reenergize sterile processing professionals and inspire systemic change.
Show, Tell, Teach: Elevating EVS Training Through Cognitive Science and Performance Coaching
April 25th 2025Training EVS workers for hygiene excellence demands more than manuals—it requires active engagement, motor skills coaching, and teach-back techniques to reduce HAIs and improve patient outcomes.
The Rise of Disposable Products in Health Care Cleaning and Linens
April 25th 2025Health care-associated infections are driving a shift toward disposable microfiber cloths, mop pads, and curtains—offering infection prevention, regulatory compliance, and operational efficiency in one-time-use solutions.
Phage Therapy’s Future: Tackling Antimicrobial Resistance With Precision Viruses
April 24th 2025Bacteriophage therapy presents a promising alternative to antibiotics, especially as antimicrobial resistance continues to increase. Dr. Ran Nir-Paz discusses its potential, challenges, and future applications in this technology.